Jonae Barnes | Senior Vice President of Investor Relations and Corporate Communications |
Jean-Pierre Sommadossi | Chief Executive Officer and Founder |
Janet Hammond | Chief Development Officer |
Arantxa Horga | Chief Medical Officer |
Andrea Corcoran | Chief Financial Officer and Executive Vice President of Legal |
John Vavricka | Chief Commercial Officer |
Maxwell Skor | Morgan Stanley |
Jessica Hui | Evercore |
Nik Gasic | Leerink Partners |
Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals Second Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions.
I would now like to turn the call over to Jonae Barnes, Senior Vice President of Investor Relations and Corporate Communications at Atea Pharmaceuticals.